Detalles de la búsqueda
1.
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial.
Ann Rheum Dis
; 80(11): 1400-1409, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33926921
2.
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.
Ann Rheum Dis
; 78(2): 192-200, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30396903
3.
Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries.
Ann Rheum Dis
; 79(6): 846-848, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32111583
4.
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci.
Ann Rheum Dis
; 79(2): e14, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30573653
5.
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al.
Ann Rheum Dis
; 79(4): e37, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30674476
6.
A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
Ann Rheum Dis
; 74(5): 867-75, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24412895
7.
Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry.
Rheumatology (Oxford)
; 54(12): 2156-65, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26175471
8.
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
Ann Rheum Dis
; 73(4): 654-61, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23434570
9.
Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry.
RMD Open
; 8(2)2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36418087
10.
Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry.
Clin Epidemiol
; 9: 627-632, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29238225
11.
Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
J Rheumatol
; 44(1): 59-69, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27909080
Resultados
1 -
11
de 11
1
Próxima >
>>